Dysbiosis of fecal virome in pediatric Crohn’s disease and its dynamic changes during infliximab therapy
mSystems · 21.04.2026 · 11 (4)
DOI: 10.1128/msystems.01489-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSystems, erschienen am 21.04.2026. Verfasst von Ting Ge und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology, and Nutrition, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai,…. Hauptthemen laut MEDLINE: Infliximab, Crohn Disease, Feces, Dysbiosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The gut virome is an emerging but underexplored component of the human microbiota, especially in pediatric Crohn’s disease (CD). This study aimed to characterize the fecal virome in children with CD and evaluate its association with clinical response to infliximab (IFX) therapy. A total of 85 participants, including 60 pediatric CD patients and 25 healthy controls (HC), were recruited. Among the CD patients, 53 received ≥3 IFX infusions, 41 achieved remission (IFX-R), and 12 did not (IFX-NR). Viral-like particles in fecal samples were enriched and profiled by metagenomic sequencing, while bacterial communities were assessed via 16S rRNA gene sequencing. Pediatric CD patients exhibited significantly reduced viral richness and altered viral community compared to HCs. Functional analyses revealed that CD patients exhibit a shift in fecal virome function from DNA repair to viral replication and assembly. Trans-kingdom correlations were disrupted in CD, particularly between Torque teno viruses and beneficial bacteria, such as Blautia . An integrated machine learning model combining viral and bacterial markers achieved a certain level of diagnostic accuracy for pediatric CD (area under the curve [AUC] = 89.3%). IFX treatment influences the gut virome, with remission associated with higher abundances of Microviridae and Siphoviridae , while Anelloviridae , Myoviridae, and Podoviridae were enriched in IFX-NR at baseline. These findings suggest the virome as a potential biomarker for predicting clinical outcome in pediatric CD, offering a novel avenue for disease diagnosis and personalized treatment strategies. IMPORTANCE Crohn’s disease (CD) in children poses a growing clinical challenge, with increasing incidence and variable response to biologic therapies such as infliximab (IFX). While gut bacterial dysbiosis has been extensively studied, the role of the gut virome in pediatric CD remains largely unexplored. This study provides the first longitudinal characterization of the fecal virome in children with CD undergoing IFX therapy. We reveal distinct viral community patterns, functional alterations, and virus-bacteria interactions in pediatric CD patients. Notably, integration of virome and bacteriome profiles enhances diagnostic accuracy, offering a promising avenue for predictive biomarker development. Furthermore, virome changes may be associated with the IFX treatment outcomes in children with CD. These findings highlight the gut virome as a critical but overlooked dimension of host-microbiome interactions in pediatric CD, with potential implications for personalized therapy and mechanistic understanding of treatment resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatology, and Nutrition, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Gut Microbiota and Metabolic Research Center, Institute of Pediatric Infection, Immunity and Critical Care Medicine, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Center for Biomedical Informatics, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Shanghai Engineering Research Center for Big Data in Pediatric Precision Medicine, Shanghai, China.
- Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
- The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen and Longgang District People's Hospital of Shenzhen, Shenzhen, China.
ORCID-Profile: Ting Ge, Tingting Zhao, Guangjun Yu, Ting Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ge, T., Zhao, T., Ruan, Y., Ye, L., Xiao, Y., Xiao, F., Li, Y., Li, X., Wang, R., Hu, H., Lu, C., Sun, H., Zhang, C., Yu, G., & Zhang, T. (2026). Dysbiosis of fecal virome in pediatric Crohn’s disease and its dynamic changes during infliximab therapy. mSystems, 11(4). https://doi.org/10.1128/msystems.01489-25
Vancouver
Ge T, Zhao T, Ruan Y, Ye L, Xiao Y, Xiao F, et al. Dysbiosis of fecal virome in pediatric Crohn’s disease and its dynamic changes during infliximab therapy. mSystems. 2026;11(4). doi:10.1128/msystems.01489-25
BibTeX
@article{Ge2026,
author = {Ge, Ting and Zhao, Tingting and Ruan, Yangming and Ye, Lin and Xiao, Yongmei and Xiao, Fangfei and Li, Youran and Li, Xiaolu and Wang, Ruixue and Hu, Hui and Lu, Chunyan and Sun, Hong and Zhang, Chiyu and Yu, Guangjun and Zhang, Ting},
title = {Dysbiosis of fecal virome in pediatric Crohn’s disease and its dynamic changes during infliximab therapy},
journal = {mSystems},
year = {2026},
volume = {11},
number = {4},
doi = {10.1128/msystems.01489-25}
}
EUVIMED